Sung Jun Ma

Assistant Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sung Jun Ma is an Assistant Professor at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in the United States. His research focuses on oncologic outcomes, radiation therapy techniques, and the impact of host factors in cancer treatment as reflected in his recent publications. Notable areas of interest include salivary duct carcinoma, non-small-cell lung cancer, and quality-of-life measurements in cancer patients.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Shankar Siva

University of Melbourne

AUSTRALIA

View details

Todd Demmy

Professor of Oncology

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Mark Farrugia

Assistant Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Darrion Mitchell

The Ohio State University Wexner Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sung Jun Ma

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma

Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma

Comparison of Survival Outcomes of Single- and Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC

Pan-Cancer Characterization of Intratumoral Autonomic Innervation in 32 Cancer Types in the Cancer Genome Atlas

Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done

Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer

A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy

Machine Learning Incorporating Host Factors for Predicting Survival in Head and Neck Squamous Cell Carcinoma Patients

A Retrospective Cohort Study of Myosteatosis and Quality of Life in Head and Neck Cancer Patients

Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome

Collaborators (4)

Shankar Siva

Todd Demmy

Mark Farrugia

Darrion Mitchell

Make your next move.